Clinical Trial Update: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [NA]

View source ↗

Summary

This clinical trial evaluated a combination of idarubicin, cytarabine, and pravastatin sodium in adults with acute myeloid leukemia or myelodysplastic syndromes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Cytarabine (Cytosar-U) (cytarabine)
• Idamycin (idarubicin)
• Pravastatin Sodium (pravastatin sodium)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | NA | Status: COMPLETED | Results posted: 2017-11-17